Facebook Linkedin Twitter
Inside Precision Medicine CRISPR-, Macrophage-Focused DEM BioPharma Launches with $70M Financing

Venture capital firm

Microscopic view of phagocytic macrophages, which are involved in the immune response within the body to conditions such as melanoma skin cancer.
News & Features

CRISPR-, Macrophage-Focused DEM BioPharma Launches with $70M Financing

0
Healthcare Technology
Informatics

AI-Based Drug Discoverer Verge Genomics Raises $32M in Series A Financing

0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine